The effect of oleuropein on apoptotic pathway regulators in breast cancer cells

Samira Asgharzade1, Somayeh Hashemi Sheikhshabani2, Elham Ghasempour1

  • 1Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord, University of Medical Sciences, Shahrekord, Iran.

Insights

Oleuropein, a natural compound from olives, shows promise in breast cancer treatment by reducing cell viability and increasing apoptosis. It modulates microRNA and gene expression, suggesting potential as a complementary cancer therapy.

Area of Science:

  • * Oncology
  • * Molecular Biology
  • * Pharmacology

Background:

  • * Breast cancer remains a leading cause of cancer-related deaths in women worldwide.
  • * MicroRNA (miRNA) dysregulation is implicated in cancer initiation and progression.
  • * Herbal compounds targeting miRNA offer a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

  • * To investigate the anticancer effects of oleuropein on human breast cancer cell lines (MCF7 and MDA-MB-231).
  • * To explore the impact of oleuropein on cell viability, apoptosis, and the expression of specific miRNAs and genes involved in cancer pathways.

Main Methods:

  • * Treatment of MCF7 and MDA-MB-231 breast cancer cells with varying doses and durations of oleuropein.
  • * Assessment of cell viability and apoptosis.
  • * Quantitative analysis of miRNA and gene expression levels (e.g., miR-125b, p53, bcl-2).

Main Results:

  • * Oleuropein significantly reduced cell viability and induced apoptosis in a dose- and time-dependent manner.
  • * Oleuropein altered the expression of key molecules, increasing tumor suppressor miRNAs (miR-125b, miR-16, miR-34a) and pro-apoptotic genes (p53, p21, TNFRS10B).
  • * Oleuropein decreased oncomiRs (miR-221, miR-29a, miR-21) and anti-apoptotic genes (bcl-2, mcl1).

Conclusions:

  • * Oleuropein exhibits significant anticancer properties against breast cancer cell lines.
  • * The mechanism involves the modulation of pro-apoptotic and anti-apoptotic factors, as well as tumor suppressor miRNAs and oncomiRs.
  • * Oleuropein represents a promising, naturally derived agent for breast cancer therapy, potentially enhancing conventional treatments.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.6K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
13.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K